IntelGenx Technologies Corp. Stock OTC Bulletin Board
Equities
IGX
US45822R1014
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CAD | - |
Sales 2022 | 950K 1.3M | Sales 2023 | 1.04M 1.42M | Capitalization | 24.12M 33.01M |
---|---|---|---|---|---|
Net income 2022 | -10M -13.68M | Net income 2023 | -9M -12.31M | EV / Sales 2022 | 44.7 x |
Net Debt 2022 | 7.98M 10.92M | Net Debt 2023 | 13.22M 18.09M | EV / Sales 2023 | 35.9 x |
P/E ratio 2022 |
-2.82
x | P/E ratio 2023 |
-2.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.6% |
Latest transcript on IntelGenx Technologies Corp.
Managers | Title | Age | Since |
---|---|---|---|
Dwight Gorham
CEO | Chief Executive Officer | 66 | 23-04-12 |
André Godin
DFI | Director of Finance/CFO | 61 | 15-07-19 |
Horst Zerbe
CHM | Chairman | 77 | 06-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Horst Zerbe
CHM | Chairman | 77 | 06-03-31 |
Mark Nawacki
BRD | Director/Board Member | 54 | 16-08-08 |
Bernd Melchers
BRD | Director/Board Member | 72 | 09-04-07 |
1st Jan change | Capi. | |
---|---|---|
+19.03% | 42.78B | |
+18.59% | 22.25B | |
+12.38% | 14.39B | |
+11.84% | 13.55B | |
+35.00% | 11.27B | |
-9.80% | 6.95B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.29% | 5.01B |
- Stock Market
- Equities
- IGXT Stock
- IGX Stock